Analysts have been eager to weigh in on the Healthcare sector with new ratings on Arrowhead Pharmaceuticals (ARWR – Research Report), Avadel Pharmaceuticals (AVDL – Research Report) and ImmunoGen (IMGN – Research Report). Arrowhead Pharmaceuticals (ARWR) In a report issued on May 26, Mani Foroohar from SVB Securities maintained a Hold rating on Arrowhead Pharmaceuticals. The company's shares closed last Friday at $34.20, close to its 52-week low of $27.87. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-arrowhead-pharmaceuticals-arwr-avadel-pharmaceuticals-avdl-and-immunogen-imgn?utm_source=advfn.com&utm_medium=referral
ImmunoGen (NASDAQ:IMGN)
Historical Stock Chart
From Oct 2022 to Nov 2022 Click Here for more ImmunoGen Charts.
ImmunoGen (NASDAQ:IMGN)
Historical Stock Chart
From Nov 2021 to Nov 2022 Click Here for more ImmunoGen Charts.